Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Uveal Melanoma × Biopsy × Clear all

Phase

Phase 1 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 11 Neoplasm Metastasis 7 Prostatic Neoplasms 6 Triple Negative Breast Neoplasms 5 Multiple Myeloma 5 Lymphoma 5 Lung Neoplasms 5 Leukemia, Myeloid, Acute 4 Lymphoma, Mantle-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Biphenotypic, Acute 3 Hematologic Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Liposarcoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2

Interventions

Ipilimumab 5 Nivolumab 4 sargramostim 2 pembrolizumab 2 binimetinib 2 aldesleukin 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 trametinib 1 tebentafusp 1 sotrastaurin 1 montanide ISA 51 1 incomplete Freund's adjuvant 1 glembatumumab vedotin 1 fludarabine 1 entrectinib 1 Tramadol 1 Thalidomide 1 Temozolomide 1 Solutions 1 Ruthenium-106 1 Radiotherapy 1 RNA, Messenger 1 Protein Kinase C 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Interleukin-2 1 Ibuprofen 1 Cyclophosphamide 1 Crizotinib 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02654821 2018-11-02

TCR

The Netherlands Cancer Institute

Phase 1/2 Unknown

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡